## Abstract Intravenous immunoglobulin (IVIg) treatment improves muscle strength in LambertβEaton myasthenic syndrome (LEMS), but its specific mode of action is unknown. We have delineated its mode of action on neuromuscular blocking properties of LEMS IgG. The effect of sera and purified IgG from
Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome
β Scribed by Willibald Gerschlager; Peter Brown
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 53 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
The therapeutic effects of intravenous immunoglobulin (IVIG) on the stiff-person syndrome (SPS) have been described exclusively in case reports or open-label studies in terms of clinical outcomes. We investigate whether IVIG improves quality of life (QoL) in the SPS. Six patients with the classic form of SPS completed a generic QoL instrument, the SF-36, and a Visual Analogue Scale (VAS) before treatment as well as 2 weeks after completion of a course of IVIG. There was significant improvement in the SF-36 subscores for pain, social functioning, general mental health, and energy-vitality with treatment. The VAS also improved significantly. We conclude that treatment with IVIG improves QoL in the SPS.
π SIMILAR VOLUMES
## Abstract ## Objectives/Hypothesis: To determine the effect of comorbidity on 1βyear postβtreatment quality of life (QOL) in patients with head and neck squamous cell cancer (HNSCC). ## Methods: One hundred twentyβfive previously untreated HNSCC patients participated in longitudinal QOL analys